Abstract
Parkinson’s disease (PD) is a progressive neurodegenerative disorder which causes debilitating symptoms in both the motor and cognitive domains. The neurophysiological markers of PD include ‘oscillopathies’ such as diffuse neural oscillatory slowing, dysregulated beta band activity, and changes in interhemispheric functional connectivity; however, the relative importance of these markers as determinants of disease status is not clear. In this study, we used resting state magnetoencephalography data (n = 199 participants, 78 PD, 121 controls) from the open OMEGA repository to investigate changes in spectral power and functional networks in PD. Using a Contrast of Parameter Estimates (COPE) approach, we modelled the effects of PD while controlling for population-level confounds (age, sex, brain volume). Permutation testing revealed highly significant increases in theta (p=0.0001) and decreases in gamma band spectral power (p=0.0001). Building on the group contrast results, we investigated the ability of source-resolved MEG data to distinguish PD from healthy controls. Our approach uses a Partial Least Squares (PLS)-based classifier to find linear combinations of MEG features which independently predict PD. We found MEG-based predictions to be highly sensitive and specific, reaching an optimal AUC-ROC of 0.87 ± 0.04 using a model including spectral power features with 4 independent PLS components, compared to 0.68 ± 0.04 when using functional connectivity. Interpretation of the model weights suggests that oscillatory slowing can be separated into independent posterior theta and global diffuse delta components that can robustly identify individual cases of PD with a high degree of accuracy. This suggests MEG can reveal dissociable, complementary neural processes which contribute to PD.
Competing Interest Statement
BTD is Chief Science Officer at MYndspan Ltd and receives consultancy payments for his work. SH & GR are employees of MYndspan Ltd.
Funding Statement
This study did not receive any funding specific the analysis of the open source data.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Research ethics board of The Hospital for Sick Children gave ethical approval for this work involving analysis of open source MEG data.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data are available from the Omega repository.
